TP53 and posterior cortical atrophy: To investigate the cell fate decisions of more aggressive PCa cells in response to radiotherapy and Olap, we selected PC-3, a metastatic, p53-mutated PCa cell line that harbours characteristics of prostatic SCNC [52].